Matrix metalloproteinase-9 involvement in the structural plasticity of dendritic spines

被引:64
|
作者
Stawarski, Michal [1 ]
Stefaniuk, Marzena [2 ]
Wlodarczyk, Jakub [1 ]
机构
[1] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, Lab Cell Biophys, PL-02093 Warsaw, Poland
[2] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, Neurobiol Lab, PL-02093 Warsaw, Poland
来源
FRONTIERS IN NEUROANATOMY | 2014年 / 8卷
关键词
matrix metalloproteinase-9; dendritic spines; structural synaptic plasticity; extracellular matrix; epilepsy; LONG-TERM POTENTIATION; MATRIX-METALLOPROTEINASE ACTIVITY; FRAGILE-X-SYNDROME; RESPONSE MEDIATOR PROTEIN-2; EXTRACELLULAR-MATRIX; TISSUE INHIBITOR; GENE-EXPRESSION; NMDA RECEPTORS; GELATINASE-B; SYNAPTIC STRUCTURES;
D O I
10.3389/fnana.2014.00068
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Dendritic spines are the locus for excitatory synaptic transmission in the brain and thus play a major role in neuronal plasticity. The ability to alter synaptic connections includes volumetric changes in dendritic spines that are driven by scaffolds created by the extracellular matrix (ECM). Here, we review the effects of the proteolytic activity of ECM proteases in physiological and pathological structural plasticity. We use matrix metalloproteinase-9 (MMP-9) as an example of an ECM modifier that has recently emerged as a key molecule in regulating the morphology and dysmorphology of dendritic spines that underlie synaptic plasticity and neurological disorders, respectively. We summarize the influence of MMP-9 on the dynamic remodeling of the ECM via the cleavage of extracellular substrates. We discuss its role in the formation, modification, and maintenance of dendritic spines in learning and memory. Finally, we review research that implicates MMP-9 in aberrant synaptic plasticity and spine dysmorphology in neurological disorders, with a focus on morphological abnormalities of dendritic protrusions that are associated with epilepsy.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Synaptically Released Matrix Metalloproteinase Activity in Control of Structural Plasticity and the Cell Surface Distribution of GluA1-AMPA Receptors
    Szepesi, Zsuzsanna
    Hosy, Eric
    Ruszczycki, Blazej
    Bijata, Monika
    Pyskaty, Marta
    Bikbaev, Arthur
    Heine, Martin
    Choquet, Daniel
    Kaczmarek, Leszek
    Wlodarczyk, Jakub
    PLOS ONE, 2014, 9 (05):
  • [22] Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation
    Li, Mingjiang
    Yang, Guokang
    Xie, Bin
    Babu, Kamesh
    Huang, Congxin
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2014, 42 (01) : 224 - 230
  • [23] Reward Learning Requires Activity of Matrix Metalloproteinase-9 in the Central Amygdala
    Knapska, Ewelina
    Lioudyno, Victoria
    Kiryk, Anna
    Mikosz, Marta
    Gorkiewicz, Tomasz
    Michaluk, Piotr
    Gawlak, Maciej
    Chaturvedi, Mayank
    Mochol, Gabriela
    Balcerzyk, Marcin
    Wojcik, Daniel K.
    Wilczynski, Grzegorz M.
    Kaczmarek, Leszek
    JOURNAL OF NEUROSCIENCE, 2013, 33 (36) : 14591 - 14600
  • [24] Polymorphisms in the Matrix Metalloproteinase-9 Promoters and Susceptibility to Glial Tumors in Turkey
    Ozden, Mahmut
    Katar, Salim
    Hanimoglu, Hakan
    Ulu, Mustafa Onur
    Isler, Cihan
    Baran, Oguz
    Antar, Veysel
    Ekmekci, Cumhur Gokhan
    Kaynar, Mehmet Yasar
    TURKISH NEUROSURGERY, 2017, 27 (05) : 690 - 695
  • [25] Matrix metalloproteinase-9 in cerebral aneurysms
    Kim, SC
    Singh, M
    Huang, J
    Prestigiacomo, CJ
    Winfree, CJ
    Solomon, RA
    Connolly, ES
    NEUROSURGERY, 1997, 41 (03) : 642 - 646
  • [26] Serum Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9/Neutrophil Gelatinase-associated Lipocalin Complex Levels in Patients with Early-stage Diabetic Nephropathy
    Cakirca, Gokhan
    Turgut, Faruk Hilmi
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2018, 12 (05) : 299 - 304
  • [27] Matrix Metalloproteinase-9 Gene and Bipolar Mood Disorder
    Rybakowski, Janusz K.
    Skibinska, Maria
    Leszczynska-Rodziewicz, Anna
    Kaczmarek, Leszek
    Hauser, Joanna
    NEUROMOLECULAR MEDICINE, 2009, 11 (02) : 128 - 132
  • [28] Increased Urinary Lipocalin-2 Reflects Matrix Metalloproteinase-9 Activity in Chronic Hepatitis C with Hepatic Fibrosis
    Kim, Jin-Wook
    Lee, Sang Hyub
    Jeong, Sook-Hyang
    Kim, Haeryoung
    Ahn, Keun Soo
    Cho, Jai Young
    Yoon, Yoo-Seok
    Han, Ho-Seong
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 222 (04) : 319 - 327
  • [29] Environmental arsenic exposure and serum matrix metalloproteinase-9
    Burgess, Jefferey L.
    Kurzius-Spencer, Margaret
    O'Rourke, Mary Kay
    Littau, Sally R.
    Roberge, Jason
    Mercedes Meza-Montenegro, Maria
    Enrique Gutierrez-Millan, Luis
    Harris, Robin B.
    JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY, 2013, 23 (02) : 163 - 169
  • [30] Matrix Metalloproteinase-9 Overexpression Regulates Hippocampal Synaptic Plasticity and Decreases Alcohol Consumption and Preference in Mice
    Yin, Li-Tian
    Xie, Xiao-Yan
    Xue, Lin-Yuan
    Yang, Xiao-Rong
    Jia, Juan
    Zhang, Yu
    Zhang, Ce
    NEUROCHEMICAL RESEARCH, 2020, 45 (08) : 1902 - 1912